Research output per year
Research output per year
Personal profile
Research interests
Immuno-oncology, hematology, survivorship care, whole blood transfusion, hemostasis, traumatic coagulopathy, non-compressible hemorrhage
Biography
Dr. Fenderson is a hematologist/medical oncologist, educator, researcher, and leader in the advancement of military oncology and battlefield resuscitation. Dr. Fenderson has extensive experience working as a clinician, educator and mentor. He is the chair of the Defense Health Agency Oncology Clinical Community where he represents all oncologists across the Agency and advises leaders on policy related to cancer care delivery. Additionally, he represent the Department of Defense interest on several White House Cancer Moonshot initiatives. Dr. Fenderson is currently a physician research scientist at the United States Army Institute of Surgical Research working to improve survival from traumatic hemorrhage and battlefield injury.
Education/Academic qualification
Hematology/Oncology, San Antonio Military Medical Center (SAMMC)
2016 → 2019
Internal Medicine, Tripler Army Medical Center
2013 → 2016
Medicine, Uniformed Services University of the Health Sciences
2009 → 2013
Biology, Bachelor, University of Nevada, Reno
2005 → 2009
Keywords
- R Medicine (General)
- Immuno-oncology
- hematology
- survivorship care
- whole blood transfusion
- hemostasis
- traumatic coagulopathy
- non-compressible hemorrhage
Fingerprint
Dive into the research topics where Joshua Fenderson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Double the trouble: pulmonary enteric adenocarcinoma with synchronous contralateral pulmonary adenocarcinoma
Yuan, K., Van Dellen, M. M. & Fenderson, J. L., 1 Mar 2025, In: Oxford Medical Case Reports. 2025, 3, omae195.Research output: Contribution to journal › Article › peer-review
Open Access -
Correction to: Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach (Journal of Cancer Survivorship, (2024), 18, 4, (1190-1199), 10.1007/s11764-024-01602-6)
the National Cancer Survivorship Standards Subject Matter Expert Group, Aug 2024, In: Journal of Cancer Survivorship. 18, 4, p. 1200 1 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach
the National Cancer Survivorship Standards Subject Matter Expert Group, Aug 2024, In: Journal of Cancer Survivorship. 18, 4, p. 1190-1199 10 p.Research output: Contribution to journal › Article › peer-review
Open Access33 Scopus citations -
Familial Essential Thrombocythemia With Novel MPL L502G and G208K Mutations
Rendo, M., Cavacece, C., Kou, C-T. J., Beeler, B. W. & Fenderson, J., Mar 2022, In: Cureus. 14, 3, p. e23220Research output: Contribution to journal › Article › peer-review
-
Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein
Christensen, B. R., Rendo, M. J., Beeler, B. W., Huddleston, B. J. & Fenderson, J. L., Mar 2022, In: Cureus. 14, 3, p. e23398Research output: Contribution to journal › Article › peer-review